Sartorius collaborates with Sanofi to

Commercialization of end-to-end platform for downstream process intensification

20-May-2024 - The life science group Sartorius is collaborating with biopharmaceutical company Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing. Selected as a preferred supplier, Sartorius will contribute its engineering and manufacturing expertise to ...

Sartorius Reviews Fiscal 2013 Results

05-Mar-2014 - The Sartorius Group closed fiscal 2013 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Group CEO Dr. Joachim Kreuzburg emphasized that the company not only achieved all financial targets, but also has successfully moved forward with its ...

Sartorius closes acquisition of TAP Biosystems Group plc

19-Dec-2013 - Sartorius successfully completed its acquisition of UK company TAP Biosystems Group plc. The cash offer made through Sartorius’ wholly owned subsidiary Sartorius Stedim Biotech valued TAP Biosystems Group plc at approximately €33 million and had been approved by TAP Biosystems’ shareholders on ...

TAP Biosystems Group plc shareholders approve Sartorius’ takeover offer

25-Nov-2013 - The shareholders of UK company TAP Biosystems Group plc approved Sartorius’ takeover offer. The cash offer made through Sartorius’ wholly-owned subsidiary Sartorius Stedim Biotech GmbH valued TAP Biosystems Group plc at approximately €33 million. The transaction is expected to close at the end of ...